Researchers studied 171 hospital patients with diabetes mellitus and found that sliding scale insulin regimens provided no benefit. Patients on standing regimens fared better than those on sliding scale regimens, which tripled the risk of hyperglycemia when used alone.
A year-long study found that implantable insulin pumps effectively controlled blood glucose levels, reduced fluctuations in blood glucose, and mild hypoglycemia by 68% compared to daily injections. The pump also eliminated weight gain associated with injections and improved patients' quality of life.
UT Southwestern Medical Center is part of a nationwide clinical study to test an oral insulin capsule on people at moderate risk for developing type I diabetes. The study aims to determine if the intervention can prevent or delay the disease.